JPH0256490A - セフアロスポリン誘導体の製造法 - Google Patents

セフアロスポリン誘導体の製造法

Info

Publication number
JPH0256490A
JPH0256490A JP1112312A JP11231289A JPH0256490A JP H0256490 A JPH0256490 A JP H0256490A JP 1112312 A JP1112312 A JP 1112312A JP 11231289 A JP11231289 A JP 11231289A JP H0256490 A JPH0256490 A JP H0256490A
Authority
JP
Japan
Prior art keywords
compound
formula
substituent
compd
cef
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1112312A
Other languages
English (en)
Japanese (ja)
Inventor
Michael George Grey
マイクル・ジヨージ・グレイ
Michael Gregson
マイクル・グレグソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPH0256490A publication Critical patent/JPH0256490A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1112312A 1988-05-03 1989-05-02 セフアロスポリン誘導体の製造法 Pending JPH0256490A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888810394A GB8810394D0 (en) 1988-05-03 1988-05-03 Chemical process
GB8810394.0 1988-05-03

Publications (1)

Publication Number Publication Date
JPH0256490A true JPH0256490A (ja) 1990-02-26

Family

ID=10636247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1112312A Pending JPH0256490A (ja) 1988-05-03 1989-05-02 セフアロスポリン誘導体の製造法

Country Status (8)

Country Link
JP (1) JPH0256490A (enrdf_load_stackoverflow)
KR (1) KR970001531B1 (enrdf_load_stackoverflow)
CH (1) CH678856A5 (enrdf_load_stackoverflow)
DE (1) DE3914658A1 (enrdf_load_stackoverflow)
FR (1) FR2631031A1 (enrdf_load_stackoverflow)
GB (2) GB8810394D0 (enrdf_load_stackoverflow)
IT (1) IT1235502B (enrdf_load_stackoverflow)
NL (1) NL8901111A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100187959B1 (ko) * 1997-03-31 1999-06-01 윤재승 저융점 무정형 세푸록심 악세틸의 제조방법
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1-乙酰氧乙酯的制备方法
IT1313569B1 (it) * 1999-07-27 2002-09-09 Antibioticos Spa Processo per la sintesi di derivati beta-lattamici.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
US4011215A (en) * 1974-08-15 1977-03-08 Glaxo Laboratories Limited 3-Chloroalkylcarbamoyloxymethyl-7-[2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acids and physiologically acceptable salts or oxides thereof
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB2018764B (en) * 1978-04-07 1982-09-02 Glaxo Group Ltd Cephalosporin compounds
CA1128930A (en) * 1978-04-07 1982-08-03 Stuart B. Laing Cephalosporin compounds
GB2034312B (en) * 1978-09-21 1983-05-11 Glaxo Group Ltd Process for the preparation of cephalosporins
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
IT8947902A0 (it) 1989-05-02
NL8901111A (nl) 1989-12-01
IT1235502B (it) 1992-09-05
CH678856A5 (enrdf_load_stackoverflow) 1991-11-15
GB8810394D0 (en) 1988-06-08
DE3914658A1 (de) 1989-11-16
FR2631031A1 (fr) 1989-11-10
GB8909987D0 (en) 1989-06-21
KR970001531B1 (ko) 1997-02-11
GB2218093A (en) 1989-11-08
KR890017256A (ko) 1989-12-15

Similar Documents

Publication Publication Date Title
JPH0313237B2 (enrdf_load_stackoverflow)
LU84717A1 (fr) Nouveaux derives de cephalosporine,leur procede de production et composition pharmaceutique les contenant
JPH01230547A (ja) 3−オキソ酪酸第三ブチルの製造法及びその用途
USRE34865E (en) Cephalosporin derivatives
US4496562A (en) 7-Substituted-3-cephem-4-carboxylic acid esters
JPS609515B2 (ja) 3′−ノルオキサセファロスポリン類
JPH0256490A (ja) セフアロスポリン誘導体の製造法
JPH041757B2 (enrdf_load_stackoverflow)
JP2599610B2 (ja) 2β―置換メチルペニシリン誘導体の製造法
JPS6341914B2 (enrdf_load_stackoverflow)
US3959266A (en) Process for the conversion of penicillin S-oxide into a corresponding desatoxycephalosporin
JPH01139586A (ja) 3−(置換)プロペニル−7−(アミノチゾリルアセトアミド)セフ−3−エム−4−カルボン酸およびそのエステル
JPS596308B2 (ja) テトラゾ−ルチオ−ル誘導体
JPS5989691A (ja) セフアロスポリンエステル
US3950329A (en) Fluorinated cephalosporins
BE893917A (fr) Derives n-imidazolyliques du 1,2,3,4-tetrahydro-naphtalene, de l'indane et du 1-chromane substitue en position 2 et procede pour les preparer
GB2051066A (en) Cephalosporin derivatives suitable for oral administration
JP2669955B2 (ja) アゼチジノン誘導体及びその製造法
JPH01186854A (ja) 2−置換オキシイミノ−3−オキソ酪酸の製造法
JPH0256489A (ja) セフアロスポリン誘導体の製法
US5306717A (en) Cephalosporin derivatives
EP0120094B1 (en) Azetidinone compounds
JPH04112891A (ja) 新規オキシム誘導体及び該誘導体を含有する抗菌剤
JPS62212391A (ja) セフエムアルコキシ基の脱離法
SU543353A3 (ru) Способ получени производных 7-монохлорацетамидо-3-дезацетоксицефалоспорановой кислоты